Muscarinic effects on action potential duration and its rate dependence in canine Purkinje fibers.
Studies of the autonomic influence on action potential duration (APD) in the ventricles show direct effects of muscarinic stimulation on epicardial, but not endocardial, APD and conflicting results regarding direct vagal effects on the conduction system. In canine Purkinje fibers, we analyzed the action of the M2 agonist oxotremorine (OXO, 0.1 microM) on APD and on its cycle length (CL) dependence. Fibers were impaled with glass microelectrodes and superfused with Tyrode's solution. APD90 was measured after 3 minutes of drive at CL between 0.3 and 5 seconds. The best fit for the APD/CL relationship at steady state was a hyperbole: APD = APDmax*CL/(CL+CL50), where APDmax (APD at infinite CL) is a rate independent measure of APD, and CL50 (CL at which 50% APDmax is reached) is an index of the rate dependence of APD. In five fibers, OXO reduced APD at all CL (P < 0.05), APDmax was also reduced to 377 +/- 41 ms from 447 +/- 34 ms (P < 0.05), while CL50 was unchanged (405 +/- 46 ms from 437 +/- 28 ms). No effects of OXO on APD and APDmax were seen in two fibers obtained from dogs pretreated with pertussis toxin (PTX). In conclusion, stimulation of M2 receptors in intact, and not PTX treated, Purkinje fibers affects APD but not its CL dependence. This may reflect the activation of a rate independent, background current through a GTP binding protein-linked pathway, such as, IK,ACh. These data differ from those obtained in endocardial and epicardial muscle, stressing the regional differences in vagal modulation of ventricular electrophysiological properties.
Malfatto
G
G
Ospedale San Luca, Centro Auxologico Italiano IRCCS, Milano, Italy.
Zaza
A
A
Vanoli
E
E
Schwartz
P J
PJ
D000109:Acetylcholine / Q000502:physiology; D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001341:Autonomic Nervous System / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D004594:Electrophysiology; D004699:Endocardium / Q000187:drug effects / Q000294:innervation; D005260:Female; D019204:GTP-Binding Proteins / Q000502:physiology; D005898:Glass; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000294:innervation; D007552:Isotonic Solutions; D008297:Male; D008839:Microelectrodes; D018721:Muscarinic Agonists / Q000494:pharmacology*; D010095:Oxotremorine / Q000494:pharmacology*; D010496:Pericardium / Q000187:drug effects / Q000294:innervation; D037342:Pertussis Toxin; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology; D011690:Purkinje Fibers / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors; D014630:Vagus Nerve / Q000187:drug effects; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D007552:Isotonic Solutions; D018721:Muscarinic Agonists; D015221:Potassium Channels; C037692:Tyrode's solution; D010566:Virulence Factors, Bordetella; D010095:Oxotremorine; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D000109:Acetylcholine